Separation Agreement and General ReleaseSeparation Agreement • October 1st, 2021 • NeuBase Therapeutics, Inc. • Pharmaceutical preparations • Pennsylvania
In order to settle as fully as possible all known and unknown claims Sam Backenroth (“Employee”) might have against NeuBase Therapeutics, Inc. (the “Company”) and all related parties, the Company and the Employee agree to the terms and conditions of this Separation Agreement and General Release (the “Agreement”) as of the Effective Date. The Employee’s employment with the Company ended on September 30, 2021 (the “Separation Date”). The “Effective Date” of this Agreement will be the date that the Employee signs and returns this Agreement to the Company.
